Skip to content
Menu

Moleculin Biotech, Inc. MBRX

Full chart Compare
Set alert

Price alert · MBRX

All alert types
7.87 USD -0.19 (-2.36%)

Regular-session close

7.82 -0.05 -0.64%

After hours · Nov 13, 4:00 PM ET

7.71 Day range 8.10
3.31 52-week range 96.20
YTD
+137.76%
1 year
-30.66%

Discussion (205)

Sign in to join the discussion

Alexander Folz MBRX 5 years ago #133

Upcoming Milestones Expectations

H2 2021: Report cohort topline results from the ongoing Phase 1/2 study for treatment of AML and report the study's topline results.

H2 2021: Commence Phase 1/2 study in Europe for the treatment of AML evaluating combination therapy of Annamycin + AraC.

H2 2021: Commencement of an investigator-funded, second Phase 1b/2 clinical trial of Annamycin in sarcoma lung metastases in Europe

Herb Bowers MBRX 5 years ago #134

I picked a higher entry price for a ton of this and I don’t care what the sp does for the next 6-12 months either way and base the investment on the aggregate potential and re-confirmation periodically. I check in about every 2 months here for any useful info but find increasingly more bs posts designed for penny ante short bets. See you in August.

Herb Bowers MBRX 5 years ago #135

Calm before the storm, investors are already in thus only volume is generated by temporary short euphoria

Herb Bowers MBRX 5 years ago #138

I own far more shares than traded so far today.

Herb Bowers MBRX 5 years ago #139

We’re in the throws of manipulation to drive sp down-I went through same thing with Immunomedics and I averaged down below $3 and then tendered close to $2MILLION in the Gild buyout at $88 sp . Playing with house money now. Have fun while you can because I don’t care.

Herb Bowers MBRX 5 years ago #140

2-H play forward, always has been! Fools play now.